Verrica Pharmaceuticals Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $11.2M | $20.6M | $30.1M | $21.1M | $15.4M | $29.6M | $46.3M | $23.0M |
| Accounts Receivable | $10.9M | $7.7M | $5.3M | $7.0M | $9.2M | $5.6M | $48.0K | $0 |
| Inventory | $2.7M | $2.0M | $2.2M | $2.3M | $2.5M | $2.5M | $2.5M | $2.6M |
| Total Current Assets | $32.6M | $34.1M | $42.5M | $36.3M | $36.8M | $39.5M | $51.2M | $28.2M |
| Property, Plant & Equipment | $177.0K | $191.0K | $209.0K | $225.0K | $315.0K | $537.0K | $589.0K | $651.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $36.0M | $38.8M | $47.1M | $40.9M | $39.1M | $42.2M | $54.1M | $32.9M |
| Liabilities | ||||||||
| Accounts Payable | $1.6M | $2.2M | $2.1M | $1.6M | $2.3M | $1.4M | $1.9M | $966.0K |
| Total Current Liabilities | $22.4M | $16.2M | $16.4M | $28.9M | $29.2M | $29.4M | $29.0M | $21.0M |
| Long-Term Debt | — | — | $0 | $21.6M | $24.6M | $27.8M | $31.0M | $43.3M |
| Total Liabilities | $31.7M | $22.7M | $22.4M | $57.9M | $56.6M | $60.8M | $64.0M | $67.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-347.7M | $-334.6M | $-324.9M | $-316.8M | $-316.6M | $-316.8M | $-307.0M | $-290.8M |
| Total Stockholders' Equity | $4.3M | $16.1M | $24.7M | $-17.0M | $-17.5M | $-18.6M | $-9.9M | $-34.1M |